Chinese (Simplified)
English
German
Korean
Spanish
Sign up for an account to enjoy easy online shopping and instant order tracking.
A cDNA encoding residues Met1 to Ser320 of the human Transcription cofactor vestigial-like protein 3 (VGLL3) full-length protein was fused with a 6xHis-tag at the N-terminus and then expressed in the yeast.?The forming recombinant protein was validated by SDS-PAGE. Its purity is greater than 90%. On the reducing SDS-PAGE gel, the VGLL3 protein migrated on the molecular mass band of approximately 38 kDa. The slightly higher result is attributed to glycosylation. This recombinant VGLL3 protein can act as the immunogen to produce specific antibodies. Besides, it also may be used in the studies of VGLL3-associated transcription. VGLL3 is a co-activator of mammalian toxicity equivalency factors (TEFs). It has reported participating in the proliferation of sarcoma and breast tumor cells. Studies revealed that VGLL3 expression was positively correlated with poor prognostic outcome in patients with gastric tumor. And gastric tumor with high levels of VGLL3 showed the activation of the MAPK, JAK-STAT, and WNT pathways together with enhanced immune infiltrates.
A cDNA encoding residues Met1 to Ser320 of the human Transcription cofactor vestigial-like protein 3 (VGLL3) full-length protein was fused with a 6xHis-tag at the N-terminus and then expressed in the yeast.?The forming recombinant protein was validated by SDS-PAGE. Its purity is greater than 90%. On the reducing SDS-PAGE gel, the VGLL3 protein migrated on the molecular mass band of approximately 38 kDa. The slightly higher result is attributed to glycosylation. This recombinant VGLL3 protein can act as the immunogen to produce specific antibodies. Besides, it also may be used in the studies of VGLL3-associated transcription.
VGLL3 is a co-activator of mammalian toxicity equivalency factors (TEFs). It has reported participating in the proliferation of sarcoma and breast tumor cells. Studies revealed that VGLL3 expression was positively correlated with poor prognostic outcome in patients with gastric tumor. And gastric tumor with high levels of VGLL3 showed the activation of the MAPK, JAK-STAT, and WNT pathways together with enhanced immune infiltrates.
| Cat.No | ACP04696 | Target Name | VGLL3 |
|---|---|---|---|
| Target Synonyms | VGLL3; Transcription cofactor vestigial-like protein 3; Vgl-3 | Form | Liquid or Lyophilized powder |
| Expression System | Yeast | Expression Range | 1-320aa |
| Mol Weight | 37.2kDa | Protein Length | Full Length of Isoform 2 |
| Purity | Greater than 90% as determined by SDS-PAGE. | Storage Buffer | 5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0. |
| Target Species | Human | Uniprot ID | A8MV65 |
|---|
Uniprot Id
A8MV65
Target Species
Human
Target Name
VGLL3
Target Full Name
Transcription cofactor vestigial-like protein 3
Target Function
May act as a specific coactivator for the mammalian TEFs.
Target Subcellular Location
Nucleus.
Target Protein Families
Vestigial family
Target Tissue Specificity
Enriched in placenta.
Target Research Area
Epigenetics and Nuclear Signaling, Transcription
Target Synonyms
VGLL3; Transcription cofactor vestigial-like protein 3; Vgl-3
Free shipping on orders $999+
Advenit post multos Scudilo Scutariorum tribunus velament
We accept credit cards, PayPal, and bank wires
Responsive and knowledgable customer service via email, text or phone
Notification
